|
|
|
|
|
|
Actinium Pharmaceuticals Inc (ATNM)
|
|
0.61 +0.02 (+3.37%)
|
9/22/2017 3:59pm
|
|
Open:
|
0.59
|
Pre. Close:
|
0.59
|
|
High:
|
0.61
|
Low:
|
0.58
|
|
Volume:
|
485,223
|
Market Cap:
|
48.81M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.61 - 0.63
|
0.63 - 0.65
|
|
Low:
|
0.55 - 0.56
|
0.56 - 0.57
|
|
Close:
|
0.58 - 0.61
|
0.61 - 0.63
|
|
|
|
|
|
|
Technical analysis (as of: 2017-09-22 4:36:56 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 0.79 One year: 0.93
|
|
Support:
|
Support1: 0.59 Support2: 0.54
|
|
Resistance:
|
Resistance1:
0.68 Resistance2: 0.79
|
|
Pivot:
|
0.62
|
|
Moving Averages:
|
MA(5): 0.61  MA(20): 0.62
MA(100): 0.99 MA(250): 1.13
|
|
MACD:
|
MACD(12,26):
-0.02 Signal(12,26,9): -0.03
|
|
%K %D:
|
%K(14,3): 18.38 %D(3): 26.53
|
|
RSI:
|
RSI(14): 44.33
|
|
52-Week:
|
High: 2.15
Low: 0.54 Change(%): -69.5
|
|
Average Vol(K):
|
3-Month: 48053
10-Days 14154
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ATNM has closed above bottom band by 31.0%. Bollinger Bands are 73.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ATNM's normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Wed, 20 Sep 2017 11:26:15 GMT
Actinium Pharmaceuticals to Participate in American Society for Blood and ...
Tue, 21 Feb 2017 12:00:00 GMT
Actinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice ...
Mon, 31 Oct 2016 10:52:30 GMT
Actinium Pharmaceuticals Announces Key Hire in Clinical Supply Chain ...
Mon, 19 Dec 2016 12:00:00 GMT
Actinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of ...
Tue, 28 Mar 2017 11:03:45 GMT
Actinium Pharmaceuticals Appoints Pharmaceutical Industry Executive Ajit S ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
